Caribou Biosciences Inc.
(CRBU)
undefined
undefined%
At close: undefined
1.84
-2.90%
After-hours Dec 13, 2024, 07:51 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Net Income | -102.07M | -99.42M | -66.92M | -34.31M | -23.43M |
Depreciation & Amortization | 3.52M | 1.62M | 984.00K | 900.00K | 751.00K |
Stock-Based Compensation | 13.75M | 11.72M | 3.45M | 1.00M | 1.23M |
Other Working Capital | -9.94M | -2.43M | 31.13M | -1.07M | -7.84M |
Other Non-Cash Items | -1.18M | -584.00K | 2.43M | -1.79M | -2.29M |
Deferred Income Tax | - | -95.00K | -1.52M | 803.00K | - |
Change in Working Capital | -7.32M | -4.20M | 29.07M | 177.00K | -8.27M |
Operating Cash Flow | -93.29M | -90.97M | -32.52M | -33.22M | -32.01M |
Capital Expenditures | -11.61M | -7.05M | -3.12M | -1.31M | -884.00K |
Acquisitions | - | 600.00K | - | 10.00K | - |
Purchase of Investments | -394.76M | -339.06M | -173.28M | -10.00K | - |
Sales Maturities Of Investments | 338.19M | 252.87M | - | 7.67M | 28.12M |
Other Investing Acitivies | - | -600.00K | -1.00M | 10.00K | 28.12M |
Investing Cash Flow | -68.18M | -93.25M | -176.40M | 6.36M | 27.23M |
Debt Repayment | - | - | 1.03M | 1.47M | -45.00K |
Common Stock Repurchased | - | - | - | - | - |
Dividend Paid | - | - | - | - | - |
Other Financial Acitivies | 1.58M | 2.13M | 111.38M | 270.00K | 217.00K |
Financial Cash Flow | 154.30M | 2.13M | 433.43M | 1.74M | 172.00K |
Net Cash Flow | -7.18M | -182.08M | 224.51M | -25.12M | -4.60M |
Free Cash Flow | -104.90M | -98.02M | -35.64M | -34.53M | -32.89M |